CYFENDUS
Pre-clinicalRecruiting 0 watching 0 views this week๐ค Quiet
15
Development Stage
1
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Anthrax
Conditions
Anthrax
Trial Timeline
Nov 1, 2035 โ Nov 1, 2037
NCT ID
NCT07268612About CYFENDUS
CYFENDUS is a pre-clinical stage product being developed by Emergent BioSolutions for Anthrax. The current trial status is recruiting. This product is registered under clinical trial identifier NCT07268612. Target conditions include Anthrax.
Hype Score Breakdown
Clinical
5
Activity
2
Company
2
Novelty
2
Community
1
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT07268612 | Pre-clinical | Recruiting |
Competing Products
15 competing products in Anthrax